Invesco Ltd. Eq Rx, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $16,208 - $22,554	9,764 Added 2.78%	360,669 $800,000
Q2 2023 Aug 11, 2023	SELL	$1.61 - $1.96 $497 - $605	-309 Reduced 0.09%	350,905 $652,000
Q1 2023 May 12, 2023	BUY	$1.8 - $2.83 $503,407 - $791,468	279,671 Added 390.91%	351,214 $681,000
Q4 2022 Feb 13, 2023	BUY	$2.05 - $5.5 $19,185 - $51,474	9,359 Added 15.05%	71,543 $175,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $1.05 Million - $6.7 Million	-1,117,985 Reduced 94.73%	62,184 $308,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $3.78 Million - $6.72 Million	1,180,169 New	1,180,169 $5.54 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.